|
|
Suzanne (Suzie) Bertisch, MD, MPH Suzanne Bertisch, MD, MPH, is an Associate Physician and Clinical Director of Behavioral Sleep Medicine at Brigham and Women's Hospital and an Assistant Professor of Medicine at Harvard Medical School. Her research focuses on 1) adapting sleep interventions for a variety of community and clinical populations and 2) examining the impact of insomnia on pain and cardiometabolic health, for which she has won several awards. Dr. Bertisch has also published on national patterns of use of insomnia treatments and has coled innovations aimed to improve the diagnosis and treatment of sleep disorders in the primary care setting. |
|
|
Elisa Gumm, DO Dr. Gumm is the Medical Director of Addiction Services at the Southern Arizona Veterans Affairs Health Care System in Tucson, AZ. She developed the University of Arizona Addiction Medicine Fellowship in 2018, and in 2020 she secured a $1.4M Health Resources and Services Administration (HRSA) grant to expand the fellowship and further enhance the infrastructure of the program. |
 |
Saira Kalia, MD Dr. Kalia is a perinatal psychiatrist, an educator, and serves as the Associate Training Director for the Department of Psychiatry Residency program at the University of Arizona College of Medicine – Tucson and runs the Psychiatry Department’s Perinatal Psychiatry Track. |
 |
Jordan Karp, MD Dr. Karp is an expert in the fields of geriatric psychiatry, depression treatment, and suicide prevention. He is committed to educating healthcare providers about the principles of psychiatry and behavioral medicine. |
|
|
Eric J. Lenze, MD Dr. Lenze is a clinical trialist who has successfully advanced evidence-based medicine for depression, anxiety, and cognitive disorders in older adults. In a series of successful and ongoing clinical trials, he has tested the benefits and risks of antidepressants, deprescribing, mindfulness, cognitive behavioral therapy, and exercise. Dr. Lenze has also advanced the concept of the Precision Clinical Trial, a framework for using clinical trials to advance precision medicine in neurobehavioral disorders. |
|
|
Jeffrey Newcorn, MD Dr. Newcorn is a Professor of Psychiatry and Pediatrics and Director of the Division of Child and Adolescent Psychiatry at Mount Sinai Medical Center in New York. He is a highly-regarded researcher in the areas of Attention-Deficit/Hyperactivity Disorder (ADHD), aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology. |
|
|
Olivia Okereke, MD, MS Dr. Okereke is a board-certified geriatric psychiatrist and associate professor of Psychiatry and associate professor of Epidemiology at Harvard Medical School and the Harvard T. H. Chan School of Public Health. She is director of Geriatric Psychiatry and Director (Research) of the Geriatric Psychiatry Clinical and Research Program at Massachusetts General Hospital. Dr. Okereke’s programmatic goals are: (1) to identify modifiable risk factors involved in adverse mental aging and (2) to translate and apply knowledge gained into strategies for large-scale prevention of late-life depression and cognitive decline. |
|
|
Kim Van Orden, PhD Dr. Van Orden is a clinical psychologist and Associate Professor in the Department of Psychiatry at the University of Rochester Medical Center. She directs the HOPE Lab (Helping Older People Engage) and co-directs the Rochester Roybal Center for Social Ties and Aging. Her lab studies programs to promote social connection and healthy aging and prevent suicide. |
